Cargando…

Longitudinal Study Reveals Long-Term Proinflammatory Proteomic Signature After Ischemic Stroke Across Subtypes

Inflammation contributes both to the pathogenesis of stroke and the response to brain injury. We aimed to identify proteins reflecting the acute-phase response and proteins more likely to reflect proinflammatory processes present before stroke by broadly profiling inflammation-related plasma protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanne, Tara M., Angerfors, Annelie, Andersson, Björn, Brännmark, Cecilia, Holmegaard, Lukas, Jern, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389938/
https://www.ncbi.nlm.nih.gov/pubmed/35686557
http://dx.doi.org/10.1161/STROKEAHA.121.038349
_version_ 1784770564772069376
author Stanne, Tara M.
Angerfors, Annelie
Andersson, Björn
Brännmark, Cecilia
Holmegaard, Lukas
Jern, Christina
author_facet Stanne, Tara M.
Angerfors, Annelie
Andersson, Björn
Brännmark, Cecilia
Holmegaard, Lukas
Jern, Christina
author_sort Stanne, Tara M.
collection PubMed
description Inflammation contributes both to the pathogenesis of stroke and the response to brain injury. We aimed to identify proteins reflecting the acute-phase response and proteins more likely to reflect proinflammatory processes present before stroke by broadly profiling inflammation-related plasma proteins in a longitudinal ischemic stroke study. METHODS: Participants were from a Swedish ischemic stroke cohort (SAHLSIS [Sahlgrenska Academy Study on Ischemic Stroke], n=600 cases and n=600 controls). Plasma levels of 65 proteins including chemokines, interleukins, surface molecules, and immune receptors were measured once in controls and at 3× in cases: during the acute phase, after 3 months, and for a subgroup (n=223) at 7-year follow-up. Associations between proteins and ischemic stroke or subtype were investigated in multivariable binary regression models corrected for age, sex, vascular risk factors, and multiple testing. RESULTS: In the acute phase, 48 proteins were significantly and independently associated with ischemic stroke (false discovery rate adjusted P<0.05). At 3-month follow-up, 51 proteins and at 7-year follow-up 50 proteins were associated with ischemic stroke. The majority of proteins were upregulated in cases compared with controls (n=34 at all time points) and the most upregulated were CXCL5 (CXC chemokine ligand 5) and OSM (oncostatin M). Generally, large artery and cardioembolic stroke had the highest protein levels. However, several interesting subtype-specific differences were also detected at each time point. CONCLUSIONS: We found inflammation-related proteins that were differentially regulated in ischemic stroke cases compared with controls only in the acute phase and others that remained elevated also at later time points. This latter group of proteins could reflect underlying pathophysiological processes of relevance. Future studies both in terms of disease risk and prognostication are warranted.
format Online
Article
Text
id pubmed-9389938
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93899382022-08-19 Longitudinal Study Reveals Long-Term Proinflammatory Proteomic Signature After Ischemic Stroke Across Subtypes Stanne, Tara M. Angerfors, Annelie Andersson, Björn Brännmark, Cecilia Holmegaard, Lukas Jern, Christina Stroke Original Contributions Inflammation contributes both to the pathogenesis of stroke and the response to brain injury. We aimed to identify proteins reflecting the acute-phase response and proteins more likely to reflect proinflammatory processes present before stroke by broadly profiling inflammation-related plasma proteins in a longitudinal ischemic stroke study. METHODS: Participants were from a Swedish ischemic stroke cohort (SAHLSIS [Sahlgrenska Academy Study on Ischemic Stroke], n=600 cases and n=600 controls). Plasma levels of 65 proteins including chemokines, interleukins, surface molecules, and immune receptors were measured once in controls and at 3× in cases: during the acute phase, after 3 months, and for a subgroup (n=223) at 7-year follow-up. Associations between proteins and ischemic stroke or subtype were investigated in multivariable binary regression models corrected for age, sex, vascular risk factors, and multiple testing. RESULTS: In the acute phase, 48 proteins were significantly and independently associated with ischemic stroke (false discovery rate adjusted P<0.05). At 3-month follow-up, 51 proteins and at 7-year follow-up 50 proteins were associated with ischemic stroke. The majority of proteins were upregulated in cases compared with controls (n=34 at all time points) and the most upregulated were CXCL5 (CXC chemokine ligand 5) and OSM (oncostatin M). Generally, large artery and cardioembolic stroke had the highest protein levels. However, several interesting subtype-specific differences were also detected at each time point. CONCLUSIONS: We found inflammation-related proteins that were differentially regulated in ischemic stroke cases compared with controls only in the acute phase and others that remained elevated also at later time points. This latter group of proteins could reflect underlying pathophysiological processes of relevance. Future studies both in terms of disease risk and prognostication are warranted. Lippincott Williams & Wilkins 2022-06-10 2022-09 /pmc/articles/PMC9389938/ /pubmed/35686557 http://dx.doi.org/10.1161/STROKEAHA.121.038349 Text en © 2022 The Authors. https://creativecommons.org/licenses/by/4.0/Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Original Contributions
Stanne, Tara M.
Angerfors, Annelie
Andersson, Björn
Brännmark, Cecilia
Holmegaard, Lukas
Jern, Christina
Longitudinal Study Reveals Long-Term Proinflammatory Proteomic Signature After Ischemic Stroke Across Subtypes
title Longitudinal Study Reveals Long-Term Proinflammatory Proteomic Signature After Ischemic Stroke Across Subtypes
title_full Longitudinal Study Reveals Long-Term Proinflammatory Proteomic Signature After Ischemic Stroke Across Subtypes
title_fullStr Longitudinal Study Reveals Long-Term Proinflammatory Proteomic Signature After Ischemic Stroke Across Subtypes
title_full_unstemmed Longitudinal Study Reveals Long-Term Proinflammatory Proteomic Signature After Ischemic Stroke Across Subtypes
title_short Longitudinal Study Reveals Long-Term Proinflammatory Proteomic Signature After Ischemic Stroke Across Subtypes
title_sort longitudinal study reveals long-term proinflammatory proteomic signature after ischemic stroke across subtypes
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389938/
https://www.ncbi.nlm.nih.gov/pubmed/35686557
http://dx.doi.org/10.1161/STROKEAHA.121.038349
work_keys_str_mv AT stannetaram longitudinalstudyrevealslongtermproinflammatoryproteomicsignatureafterischemicstrokeacrosssubtypes
AT angerforsannelie longitudinalstudyrevealslongtermproinflammatoryproteomicsignatureafterischemicstrokeacrosssubtypes
AT anderssonbjorn longitudinalstudyrevealslongtermproinflammatoryproteomicsignatureafterischemicstrokeacrosssubtypes
AT brannmarkcecilia longitudinalstudyrevealslongtermproinflammatoryproteomicsignatureafterischemicstrokeacrosssubtypes
AT holmegaardlukas longitudinalstudyrevealslongtermproinflammatoryproteomicsignatureafterischemicstrokeacrosssubtypes
AT jernchristina longitudinalstudyrevealslongtermproinflammatoryproteomicsignatureafterischemicstrokeacrosssubtypes